Close
CDMO Safety Testing 2026
Novotech

Envision Pharma Group launches 4Sight to drive AI and technology performance in healthcare

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

eschbach Unveils Seqonis Intelligent Operations Platform

eschbach has renamed its flagship enterprise software platform, Shiftconnector,...

Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub

Agilent Technologies and Veeda Lifesciences have announced a strategic...

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...
- Advertisement -

Leading global technology solutions partner Envision Pharma Group (Envision) has launched 4Sight, a new AI and technology-enabled approach designed to help medical affairs teams optimize raw data and turn it into actionable insights for healthcare professionals.

4Sight represents Envisionโ€™s innovative method for navigating the medical affairs insight journey. Powered by OKRA.ai and Envisionโ€™s proprietary technology as the platform, it offers a comprehensive strategy that aligns the right combination of platform, people, and process to empower teams and achieve exceptional performance in medical affairs. Rather than relying on individual components, 4Sight adopts a holistic solution to optimize your efforts.

At the core of 4Sight is the recognition that even the most advanced tools and platforms are only as effective as the people and processes that support them. By providing the right training, resources, and operating procedures, this methodology helps medical affairs teams unlock the full potential of their data and insights.

Dominic Marasco, Executive President and Chief Commercial Officer at Envision, says, โ€œThe life sciences sector is suffering from a fear of making the wrong decisions in tech-enablement right now. With significant groundswell in all things AI, companies are trying to balance choosing the right path forward and not being left behind, while navigating a landscape that feels unfamiliar to them.โ€

Marasco notes that while everyone has access to an AI tool nowadays, they often lack specialization for the intricacies of the life sciences field. With 4Sightโ€™s targeted approach, which integrates the necessary rigor and human touch required to enable medical decision-making, raw data is transformed into actionable insights that resonate with healthcare professionals, leading to measurable healthcare outcomes.

He adds, โ€œWith more than 20 years of industry experience, we aim to help the life sciences industry with best-in-class AI platform launches using our 4Sight approach. The 4Sight offering includes using OKRA.aiโ€™s AI platform, a state-of-the-art AI solution that compiles healthcare data from multiple sources โ€“ covering hundreds of therapeutic areas, thousands of clinical trials and publications, and billions of data points.โ€

4Sight is designed to give businesses a competitive edge in a rapidly changing market. You can learn more about Envisionโ€™s innovative AI and technology solutions here.

Envision Pharma Group
Company Logo

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

eschbach Unveils Seqonis Intelligent Operations Platform

eschbach has renamed its flagship enterprise software platform, Shiftconnector,...

Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub

Agilent Technologies and Veeda Lifesciences have announced a strategic...

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป